These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33866410)

  • 1. Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma.
    Rickert D; Bartl J; Picard D; Bernardi F; Qin N; Lovino M; Puget S; Meyer FD; Mahoungou Koumba I; Beez T; Varlet P; Dufour C; Fischer U; Borkhardt A; Reifenberger G; Ayrault O; Remke M
    Acta Neuropathol; 2021 Jun; 141(6):975-978. PubMed ID: 33866410
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA-methylation profiling discloses significant advantages over NanoString method for molecular classification of medulloblastoma.
    Korshunov A; Chavez L; Northcott PA; Sharma T; Ryzhova M; Jones DTW; von Deimling A; Pfister SM; Kool M
    Acta Neuropathol; 2017 Dec; 134(6):965-967. PubMed ID: 29027579
    [No Abstract]   [Full Text] [Related]  

  • 3. Medulloblastoma: Molecular Classification-Based Personal Therapeutics.
    Archer TC; Mahoney EL; Pomeroy SL
    Neurotherapeutics; 2017 Apr; 14(2):265-273. PubMed ID: 28386677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours.
    Lindsey JC; Schwalbe EC; Potluri S; Bailey S; Williamson D; Clifford SC
    Acta Neuropathol; 2014 Feb; 127(2):307-9. PubMed ID: 24337442
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies.
    Schwalbe EC; Williamson D; Lindsey JC; Hamilton D; Ryan SL; Megahed H; Garami M; Hauser P; Dembowska-Baginska B; Perek D; Northcott PA; Taylor MD; Taylor RE; Ellison DW; Bailey S; Clifford SC
    Acta Neuropathol; 2013 Mar; 125(3):359-71. PubMed ID: 23291781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBM5 Acts as Tumor Suppressor in Medulloblastoma through Regulating Wnt/β-Catenin Signaling.
    Yu J; Ji G; Shi W; Zhao R; Shen W; Zheng J; Li H; Jiang F
    Eur Neurol; 2020; 83(3):242-250. PubMed ID: 32610314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
    Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
    J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas.
    Korshunov A; Sahm F; Zheludkova O; Golanov A; Stichel D; Schrimpf D; Ryzhova M; Potapov A; Habel A; Meyer J; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M
    Neuro Oncol; 2019 Feb; 21(2):214-221. PubMed ID: 30252101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.
    Łastowska M; Trubicka J; Niemira M; Paczkowska-Abdulsalam M; Karkucińska-Więckowska A; Kaleta M; Drogosiewicz M; Perek-Polnik M; Krętowski A; Cukrowska B; Grajkowska W; Dembowska-Bagińska B; Matyja E
    J Neurooncol; 2018 Jun; 138(2):231-240. PubMed ID: 29427151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNT/β-catenin pathway activation in Myc immortalised cerebellar progenitor cells inhibits neuronal differentiation and generates tumours resembling medulloblastoma.
    Rogers HA; Sousa S; Salto C; Arenas E; Coyle B; Grundy RG
    Br J Cancer; 2012 Sep; 107(7):1144-52. PubMed ID: 22929883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling pathway and molecular subgroups of medulloblastoma.
    Li KK; Lau KM; Ng HK
    Int J Clin Exp Pathol; 2013; 6(7):1211-22. PubMed ID: 23826403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.
    Phoenix TN; Patmore DM; Boop S; Boulos N; Jacus MO; Patel YT; Roussel MF; Finkelstein D; Goumnerova L; Perreault S; Wadhwa E; Cho YJ; Stewart CF; Gilbertson RJ
    Cancer Cell; 2016 Apr; 29(4):508-522. PubMed ID: 27050100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.
    Hovestadt V; Remke M; Kool M; Pietsch T; Northcott PA; Fischer R; Cavalli FM; Ramaswamy V; Zapatka M; Reifenberger G; Rutkowski S; Schick M; Bewerunge-Hudler M; Korshunov A; Lichter P; Taylor MD; Pfister SM; Jones DT
    Acta Neuropathol; 2013 Jun; 125(6):913-6. PubMed ID: 23670100
    [No Abstract]   [Full Text] [Related]  

  • 14. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
    Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
    J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down-regulation of microRNA-31.
    Chen Y; Shang H; Zhang S; Zhang X
    J Cell Biochem; 2018 Aug; 119(8):6527-6534. PubMed ID: 29377269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpressed TP73 induces apoptosis in medulloblastoma.
    Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
    BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation.
    Park AK; Lee SJ; Phi JH; Wang KC; Kim DG; Cho BK; Haberler C; Fattet S; Dufour C; Puget S; Sainte-Rose C; Bourdeaut F; Grill J; Delattre O; Kim SK; Park WY
    Neuro Oncol; 2012 Feb; 14(2):203-14. PubMed ID: 22090452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular fingerprint for medulloblastoma.
    Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
    Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medulloblastoma genomics in the modern molecular era.
    Kumar R; Liu APY; Northcott PA
    Brain Pathol; 2020 May; 30(3):679-690. PubMed ID: 31799776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human hedgehog interacting protein expression and promoter methylation in medulloblastoma cell lines and primary tumor samples.
    Shahi MH; Afzal M; Sinha S; Eberhart CG; Rey JA; Fan X; Castresana JS
    J Neurooncol; 2011 Jun; 103(2):287-96. PubMed ID: 20853133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.